FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

764296002: Prolonged-release subcutaneous implant (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3647392011 Prolonged-release subcutaneous implant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3647393018 Prolonged-release subcutaneous implant (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release subcutaneous implant Has dose form administration method (attribute) Insert (administration method) false Inferred relationship Some
Prolonged-release subcutaneous implant Has dose form transformation (attribute) No transformation true Inferred relationship Some
Prolonged-release subcutaneous implant Has dose form intended site (attribute) Subcutaneous (intended site) true Inferred relationship Some
Prolonged-release subcutaneous implant Has dose form release characteristic (attribute) Prolonged-release (release characteristic) true Inferred relationship Some
Prolonged-release subcutaneous implant Has basic dose form (attribute) Implant true Inferred relationship Some
Prolonged-release subcutaneous implant Is a Subcutaneous dose form true Inferred relationship Some
Prolonged-release subcutaneous implant Has dose form administration method (attribute) Implantation (administration method) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Estradiol 100 mg prolonged-release subcutaneous implant Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
etonogestrel 68 mg implantat til subkutan anvendelse Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Some
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Testosterone 100 mg prolonged-release subcutaneous implant Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Testosterone 200 mg prolonged-release subcutaneous implant Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Levonorgestrel 75 mg prolonged-release subcutaneous implant Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Product containing precisely etonogestrel 68 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some

This concept is not in any reference sets

Back to Start